Compensation 990

Transcelerate Biopharma Inc.

Fiscal year ending 2024. Filed on May 14, 2025.

300 Conshohocken State Road 420
West Conshohocken, Pennsylvania 19428

Transcelerate Biopharma Inc. (EIN: 46-0886344) has filed an IRS Form 990 since at least fiscal year 2016. In its fiscal year 2024 IRS Form 990 filing, Transcelerate Biopharma Inc., a 501(c)(6) business league, reported compensation for 9 out of 33 total employees. Among the employees shown here, the average compensation is $578,267. The highest compensated employee at Transcelerate Biopharma Inc. is Janice Chang with fiscal year 2024 compensation of $1,104,805.

Revenue, expenses, and employee compensation

Revenue

$38,595,799

Expenses

$31,739,939

Employee compensation

$9,759,153
Revenue, expenses, and employee compensation over time

Reported Compensated Employees

－0.1%vs 2023
Janice Chang
Chief Executive Officer
$1,104,805
$1,062,291 from orgNo related comp$42,514 other
＋97.8%vs 2023
Allison Cuff Shimooka
Chief Operating Officer
$636,164
$582,003 from orgNo related comp$54,161 other
－17.6%vs 2023
Jennifer A Burgess
Vice President, Global Communications and Engagement
$505,598
$461,236 from orgNo related comp$44,362 other
－18.1%vs 2023
Cara L Rinaldi
Vice President, Portfolio Management
$470,686
$417,189 from orgNo related comp$53,497 other
＋5.8%vs 2023
Robert Dicicco
Vice President, Portfolio Management
$455,753
$389,486 from orgNo related comp$66,267 other
－16.7%vs 2023
Anthony Garges
HEAD of Finance and Administration
$445,085
$397,818 from orgNo related comp$47,267 other
－17.2%vs 2023
Jeneen Donadeo
EXEC Portfolio Director
$429,776
$395,823 from orgNo related comp$33,953 other
Andrew Lee
Treasurer
$0
Stephen Lin
Secretary (Thru 11/2024)
$0

Non-Employee Board Members

Badhri Srinivasan
VICE Chair of Board of Director
Bari Kowal
Board Member
Chris Corsico
Board Member
Christoph Koenen
Board Member
Cristian Massacesi
Board Member
Dietmar Berger
Board Member
Eliav Barr
Board Member
Fabio Lievano
Board Member (EFF 11/2024)
Iris Loew-Friedrich
Board Member
Kathryn Owen
Chair of Board of Directors
Lykke Hinsch Gylvin
Board Member (EFF 6/2024)
Maria Koutsopoulou
Board Member

Contractors

＋9.9%vs 2023
PA Consulting Group Inc.
Consulting
$7,607,821
－36.1%vs 2023
Accenture LLP
Consulting and IT
$3,059,291
＋15.2%vs 2023
Kilpatrick Townsend
Legal
$3,024,932
－12.6%vs 2023
Cdisc
Consulting
$1,174,012
－57.8%vs 2023
Artemis Factor LLC
Consulting
$942,230

Mission Statement

THE ORGANIZATION'S MISSION IS TO COLLABORATE ACROSS THE GLOBAL BIOPHARMACEUTICAL R&D COMMUNITY TO IDENTIFY, DESIGN AND FACILITATE IMPLEMENTATION OF SOLUTIONS DESIGNED TO DRIVE THE EFFICIENT, EFFECTIVE AND HIGH QUALITY DELIVERY OF NEW MEDICINES.

Revisions to this organization profile

May 14, 2025:
2024 Transcelerate Biopharma Inc. 990 filed
May 14, 2024:
2023 Transcelerate Biopharma Inc. 990 filed
May 11, 2023:
2022 Transcelerate Biopharma Inc. 990 filed

Get an email when new compensation information is released for Transcelerate Biopharma Inc.

Be the first to know when new IRS Form 990 data is published for this organization.

Related Jobs

View more jobs
Powered by Talroo
Report a discrepancy →